On Wednesday, providers from Highland Hospital made another donation to support global efforts to treat cystic fibrosis.

James Boudreau was diagnosed with cystic fibrosis as a child. The disease comes with immense difficulties, but Boudreau is still looking to challenge himself. Trump admin suffers blow in James Comey ...

BOSTON RED SOX PLAYER. MIKE GREENWELL, NOW 62 YEARS OLD AND LIVING IN FLORIDA, SAYS HE’S BEEN DIAGNOSED WITH MEDULLARY THYROID CANCER. GREENWELL BECAME A FAN FAVORITE IN 1988 AFTER REPLACING HALL OF ...

There is some confusion regarding previous and current terminology of the diseases mentioned (especially with regard to autosomal dominant medullary cystic kidney disease). According to PMID:25738250 ...

Cystic fibrosis (CF) is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive system and other organs Morgan Barrett; Brittyn Elizabeth Studios From a very young age, ...

Cystic fibrosis is a genetic disorder that affects roughly 40,000 Americans. The condition is caused by a mutation in the patient's cystic fibrosis transmembrane conductance regulator (CFTR) gene, ...

Imagine a future where treating cystic fibrosis is as simple as taking a deep breath. That’s exactly what a team of pediatric physician-scientists at the Eli and Edythe Broad Center of Regenerative ...

What Is Medullary Carcinoma Thyroid (MTC)? Medullary carcinoma is a rare type of cancer that can appear in different parts of the body. It most commonly shows up in the thyroid gland and the colon.

Anyone, of any ethnicity, can get cystic fibrosis. But for decades it has been overlooked in people of color, leading to misdiagnoses and dismal health disparities. Terry Wright takes a pulmonary ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...

The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer. The Food and Drug Administration (FDA) approved Retevmo ...

ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical ...